Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia (Q44552183)

4 December 2017

title

Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia (English)

1 reference

4 December 2017

1 reference

Verseyden C

1

1 reference

4 December 2017

Meijssen S

2

1 reference

4 December 2017

van Dijk H

3

1 reference

4 December 2017

Jansen H

4

1 reference

4 December 2017

Castro Cabezas M

5

1 reference

4 December 2017

publication date

16 August 2003

1 reference

Journal of Lipid Research

4 December 2017

published in

1 reference

4 December 2017

volume

44

1 reference

4 December 2017

issue

11

1 reference

4 December 2017

page(s)

2100-2108

1 reference

Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Increased intima-media thickness in familial combined hyperlipidemia associated with apolipoprotein B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Coronary flow reserve in young men with familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Relationship of insulin sensitivity and ApoB levels to intra-abdominal fat in subjects with familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Serum complement and familial combined hyperlipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Locus for elevated apolipoprotein B levels on chromosome 1p31 in families with familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Impaired insulin-stimulated glucose oxidation and free fatty acid suppression in patients with familial combined hyperlipidemia: a precursor defect for dyslipidemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Impaired free fatty acid suppression during hyperinsulinemia is a characteristic finding in familial combined hyperlipidemia, but insulin resistance is observed only in hypertriglyceridemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Effects of atorvastatin on postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Atorvastatin improves postprandial lipoprotein metabolism in normolipidemlic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

The adipocyte, fatty acid trapping, and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Postprandial elevation of ApoB-48-containing triglyceride-rich particles and retinyl esters in normolipemic males who smoke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Replication of Linkage of Familial Combined Hyperlipidemia to Chromosome 1q With Additional Heterogeneous Effect of Apolipoprotein A-I/C-III/A-IV Locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Serum C3 but not plasma acylation-stimulating protein is elevated in Finnish patients with familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

Evidence for complement activation in ruptured coronary plaques in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300201-JLR200

10.1194/JLR.M300201-JLR200

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference